Company: GDSTR
Filing Date: 2025-06-20
Form Type: S-4/A
Source: 0001213900-25-055744
Chunk: 256

Company: Goldenstone Acquisition Ltd.
Filing Date: 2025-06-20
Form: S-4/A
Chunk 256
---
 |     |    1,999,500 |     |       6.8 | % |
| Representative Shares(6)                                               |     |      839,900 |     |       2.7 | % |     |      839,900 |     |       2.9 | % |
| Shares underlying from the Senior Secured Convertible Note Investor(7) |     |      531,915 |     |       1.7 | % |     |      531,915 |     |       1.8 | % |
| Infintium Shareholders(8)                                              |     |   19,329,593 |     |      62.9 | % |     |   19,329,593 |     |      65.7 | % |
| Shares initially reserved for issuance under the Equity Incentive Plan |     |    3,000,000 |     |       9.8 | % |     |    3,000,000 |     |      10.2 | % |
| Total                                                                  |     |   30,746,779 |     |     100.0 | % |     |   29,414,962 |     |     100.0 | % |

(4)Including the exercise of 5,750,000 of Goldenstone Public Warrants, for which, each warrant entitles the holder thereof to purchase one -halfshare of Goldenstone common stock at an exercise price of $11.50 per full share and the issuance of 575,000shares converted from the Goldenstone public rights.

137 (5)Including the exercise of 351,250 of Goldenstone private warrants, for which, each warrant entitles the holder thereof to purchase one -halfshare of Goldenstone common stock at an exercise price of $11.50 per full share and the issuance of 35,125shares converted from the Goldenstone private rights. (6)Including the issuance of 270,250 Goldenstone common stock, the exercise of 270,250 warrants, for which, each warrant entitles the holder thereof to purchase one -halfshare of Goldenstone common stock at an exercise price of $11.50 per full share, and the issuance of 27,025shares converted from the rights underlying from the UPO. (7)Including the assumed conversion of the $5.0million senior secured convertible note using an assumed conversion price of $9.40 at the